Ying‐Ju Lai

1.6k total citations
40 papers, 1000 citations indexed

About

Ying‐Ju Lai is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ying‐Ju Lai has authored 40 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ying‐Ju Lai's work include Pulmonary Hypertension Research and Treatments (16 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Ying‐Ju Lai is often cited by papers focused on Pulmonary Hypertension Research and Treatments (16 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Ying‐Ju Lai collaborates with scholars based in Taiwan, United States and Germany. Ying‐Ju Lai's co-authors include Wei-Jan Chen, Gwo‐Jyh Chang, Yung‐Hsin Yeh, Jong‐Hwei S. Pang, Chung-Chi Huang, Shang‐Hung Chang, Yi‐Hsin Chan, Norbert Weißmann, Ralph T. Schermuly and Chi‐Tai Kuo and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Ying‐Ju Lai

38 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying‐Ju Lai Taiwan 19 385 353 284 114 107 40 1000
David Loch Australia 12 285 0.7× 347 1.0× 278 1.0× 79 0.7× 135 1.3× 15 1.0k
Cui Tian China 20 149 0.4× 395 1.1× 180 0.6× 134 1.2× 113 1.1× 31 917
Kenji Kuwabara Japan 14 253 0.7× 315 0.9× 133 0.5× 167 1.5× 92 0.9× 23 938
Jinxiu Lin China 19 170 0.4× 372 1.1× 246 0.9× 203 1.8× 185 1.7× 75 952
Navid Koleini Canada 13 132 0.3× 373 1.1× 397 1.4× 125 1.1× 76 0.7× 30 1.0k
Rongjun Zou China 15 141 0.4× 547 1.5× 201 0.7× 167 1.5× 82 0.8× 50 1.0k
Konrad Teodor Sawicki United States 13 151 0.4× 439 1.2× 227 0.8× 110 1.0× 77 0.7× 24 957
Chunpeng Zou China 14 100 0.3× 310 0.9× 211 0.7× 75 0.7× 92 0.9× 35 799

Countries citing papers authored by Ying‐Ju Lai

Since Specialization
Citations

This map shows the geographic impact of Ying‐Ju Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐Ju Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐Ju Lai more than expected).

Fields of papers citing papers by Ying‐Ju Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying‐Ju Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐Ju Lai. The network helps show where Ying‐Ju Lai may publish in the future.

Co-authorship network of co-authors of Ying‐Ju Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Ying‐Ju Lai. A scholar is included among the top collaborators of Ying‐Ju Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying‐Ju Lai. Ying‐Ju Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lai, Ying‐Ju, et al.. (2025). The role and regulatory mechanisms of the TCA cycle in early embryonic development. Frontiers in Cell and Developmental Biology. 13. 1662431–1662431.
3.
Lai, Ying‐Ju, Shang‐Hung Chang, Ying‐Chang Tung, et al.. (2024). Naringin activates semaphorin 3A to ameliorate TGF‐β‐induced endothelial‐to‐mesenchymal transition related to atrial fibrillation. Journal of Cellular Physiology. 239(5). e31248–e31248. 8 indexed citations
4.
Chang, Chi‐Jen, Ying‐Ju Lai, Ying‐Chang Tung, et al.. (2023). Osteopontin mediation of disturbed flow–induced endothelial mesenchymal transition through CD44 is a novel mechanism of neointimal hyperplasia in arteriovenous fistulae for hemodialysis access. Kidney International. 103(4). 702–718. 18 indexed citations
5.
Chan, Yi‐Hsin, Feng‐Chun Tsai, Gwo‐Jyh Chang, et al.. (2023). CD44 regulates Epac1-mediated β-adrenergic-receptor-induced Ca2+-handling abnormalities: implication in cardiac arrhythmias. Journal of Biomedical Science. 30(1). 55–55. 6 indexed citations
6.
Lai, Ying‐Ju, Winston W.‐Y. Kao, Yung‐Hsin Yeh, Wei-Jan Chen, & Pao‐Hsien Chu. (2021). Lumican deficiency promotes pulmonary arterial remodeling. Translational research. 237. 63–81. 11 indexed citations
7.
Lai, Ying‐Ju, et al.. (2021). Effects of positive end-expiratory pressure on the predictability of fluid responsiveness in acute respiratory distress syndrome patients. Scientific Reports. 11(1). 10186–10186. 3 indexed citations
8.
Chen, Wei-Jan, Ying‐Ju Lai, Jia-Lin Lee, Sheng‐Tang Wu, & Yu‐Juei Hsu. (2020). CREB/ATF3 signaling mediates indoxyl sulfate-induced vascular smooth muscle cell proliferation and neointimal formation in uremia. Atherosclerosis. 315. 43–54. 19 indexed citations
9.
Lai, Ying‐Ju, et al.. (2019). Unique wreath-like smooth muscle proliferation of the pulmonary vasculature in pulmonary veno-occlusive disease versus pulmonary arterial hypertension. Journal of the Formosan Medical Association. 119(1). 300–309. 4 indexed citations
10.
Chan, Yi‐Hsin, Gwo‐Jyh Chang, Ying‐Ju Lai, et al.. (2019). Atrial fibrillation and its arrhythmogenesis associated with insulin resistance. Cardiovascular Diabetology. 18(1). 125–125. 102 indexed citations
11.
Chen, Wei-Jan, Shang‐Hung Chang, Yi‐Hsin Chan, et al.. (2019). Tachycardia-induced CD44/NOX4 signaling is involved in the development of atrial remodeling. Journal of Molecular and Cellular Cardiology. 135. 67–78. 18 indexed citations
12.
Lai, Ying‐Ju, et al.. (2017). Photocytotoxic Copper(II) Complexes with Schiff‐Base Scaffolds for Photodynamic Therapy. Chemistry - A European Journal. 24(16). 4111–4120. 39 indexed citations
13.
Lai, Ying‐Ju, Hsao‐Hsun Hsu, Gwo‐Jyh Chang, et al.. (2017). Prostaglandin E1 Attenuates Pulmonary Artery Remodeling by Activating Phosphorylation of CREB and the PTEN Signaling Pathway. Scientific Reports. 7(1). 9974–9974. 9 indexed citations
14.
Chen, Wei-Jan, Ying‐Hwa Chen, Ying‐Ju Lai, et al.. (2016). GT-repeat length polymorphism in heme oxygenase-1 promoter determines the effect of cilostazol on vascular smooth muscle cells. International Journal of Cardiology. 222. 407–415. 8 indexed citations
15.
Lai, Ying‐Ju, Gwo‐Jyh Chang, Yung‐Hsin Yeh, et al.. (2015). Propylthiouracil Attenuates Experimental Pulmonary Hypertension via Suppression of Pen-2, a Key Component of Gamma-Secretase. PLoS ONE. 10(9). e0137426–e0137426. 15 indexed citations
16.
Kosanovic, Djuro, Tian Xia, Oleg Pak, et al.. (2013). Rhodiola: An Ordinary Plant or a Promising Future Therapy for Pulmonary Hypertension? A Brief Review. Pulmonary Circulation. 3(3). 499–506. 27 indexed citations
17.
Pérez, Vinicio A. de Jesús, Ziad A. Ali, Tero-Pekka Alastalo, et al.. (2011). BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathways. The Journal of Cell Biology. 192(1). 171–188. 58 indexed citations
18.
19.
Dahal, Bhola K., Djuro Kosanovic, Akylbek Sydykov, et al.. (2010). Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension. European Respiratory Journal. 36(4). 808–818. 44 indexed citations
20.
Lai, Ying‐Ju, Soni Savai Pullamsetti, Eva Dony, et al.. (2008). Role of the Prostanoid EP4 Receptor in Iloprost-mediated Vasodilatation in Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 178(2). 188–196. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Loch Breakdown of academic impact, for papers by Cui Tian Breakdown of academic impact, for papers by Kenji Kuwabara Breakdown of academic impact, for papers by Jinxiu Lin Breakdown of academic impact, for papers by Navid Koleini Breakdown of academic impact, for papers by Rongjun Zou Breakdown of academic impact, for papers by Konrad Teodor Sawicki Breakdown of academic impact, for papers by Chunpeng Zou
Rankless by CCL
2026